| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |